Atazanavir

dm+d

413591007

Articles

20th May 2012

Breastfeeding by HIV-positive mothers may cause HIV infection in the infant and should be avoided where possible. The use of HIV drugs during breastfeeding is… Abacavir Atazanavir Darunavir Didanosine Efavirenz Emtricitabine Enfuvirtide Etravirine Fosamprenavir Indinavir Lamivudine Lopinavir + Ritonavir Maraviroc Nelfinavir Nevirapine Raltegravir Rilpivirine Ritonavir Saquinavir Stavudine Tenofovir Tenofovir disoproxil Tipranavir Zidovudine

Manufacturer

Bristol-Myers Squibb Pharmaceutical Ltd

Trade Name

Reyataz

Formulation

Capsules 150mg, 200mg, 300mg

Recommendation

A1 · Amber 1 · Stability data is available in an alternative container (not CAs) that may be extrapolated to support storage in CAs.

Recommendation Notes

No special precautions for storage

Theoretical Concerns

No special precautions for storage.

Review Date

3rd August 2015

MCA Overview

Use when breastfeeding

Comments

Specialist drug/complex disease area for which expert advice is recommended

Therapeutic group summary

Evidence link